---------------------------------------------------------------------------
Emerging Infectious Diseases * Volume 2 * Number 4 * October-December 1996
---------------------------------------------------------------------------
News and Notes

A Global Theme Issue: Bibliography of References

---------------------------------------------------------------------------


    Emerging and reemerging infections respect no national boundaries;
    therefore, they were an appropriate topic for the first "global
    medical theme issue," introduced in January 1996. This global
    theme issue was conceived by three editors, Linda Hawes Clever,
    The Western Journal of Medicine, Magne Nylenna, Journal of the
    Norwegian Medical Association, and George D. Lundberg, Journal of
    the American Medical Association, who in 1995 invited the editors
    of 78 journals worldwide to participate. A year later, 36 journals
    in 21 countries on six continents published more than 200 articles
    pertaining to emerging and reemerging global microbial threats
    (1). The articles addressed topics ranging from factors
    contributing to increasing antimicrobial resistance to the impact
    of global warming on infectious disease. While some solutions were
    suggested, the global issue primarily served as a call to medical
    communities and people worldwide to identify contributing factors
    and begin to develop strategies to control emergent infections.

    Following this note is a bibliography of articles published by the
    36 journals participating in the global theme issue.

Margaret A. Winker
Journal of the American Medical Association, Chicago, Illinois, USA
                             [end of page 365]

Bibliography of References

  1. Addy PAK, Esani RK, Atusheno SKN. Possible contributing factors to the
     paucity of yellow fever epidemic in the Ashanti Region of Ghana, West
     Africa. East Afr Med J 1996;73:3-9.
  2. Adlestein S, McKnight I, Pethebridge AM. HIV and intermediate immune
     deficiency. Med J Aust 1996;164:109-10.
  3. Aita J, Barrera L, Reniero A, et al. Hospital transmission of
     multidrug resistant Mycobacterium tuberculosis in Rosario Argentina.
     Medicina 1996;56:48-50.
  4. Albrecht H, Sobottka I, Emminger C, et al. Visceral leishmaniasis
     emerging as an important opportunistic infection in HIV-infected
     persons living in areas non-endemic for Leishmania donovani. Arch
     Pathol Lab Med 1996;120:189-98.
  5. Altekruse SF, Swerdlow DL. The changing epidemiology of foodborne
     diseases. Am J Med Sci 1996;311:23-9.
  6. Aseffa A, Yohannes G. Antibiotic sensitivity pattern of prevalent
     bacterial pathogens in Gondar, Ethiopia. East Afr Med J 1996;73:67-71.
  7. Bakken JS, Krueth MT, Wilson-Nordskog C, Tilden RL, Asanovich K,
     Dumler JS. Clinical and laboratory characteristics of human
     granulocytic ehrlichiosis (HGE). JAMA 1996;275:199-205.
  8. Bán E. Changes in the role of gram-positive bacteria in the infections
     of immunocompromised patients. LAM 1996;6:pages not available.
  9. Banerjee G, Ayyagari A, Prasad KN, Dhole TN, Singh SK. Nosocomial
     infection due to Enterobacter cloacae in a tertiary care hospital in
     Northern India. Indian J Med Res 1996;103:62-3.
 10. Bánhegyi D. Current situation of HIV/AIDS in Hungary. LAM 1996;6:pages
     not available.
 11. Barbour AG. Does Lyme disease occur in the South? Am J Med Sci
     1996;311:34-40.
 12. Barnes PF, El-Hajj H, Preston-Martin S, et al. Transmission of
     tuberculosis among the urban homeless. JAMA 1996;275:305-7.
 13. Barton LL, Jeck DT, Vaidya VU. Necrotizing fascitis in children:
     report of two cases and review of the literature. Arch Pediatr Adolesc
     Med 1996;150:105-8.
 14. Berkelman RL, Pinner RW, Hughes JM. Addressing emerging microbial
     threats in the United States. JAMA 1996;275:315-7.
 15. Beyers AD, Donald PR, van Helden PD, Ehlers MRW, Steyn L, Mizrahi V.
     Tuberculosis research - the way forward. S Afr Med J 1996;86:30-3.
 16. Beyers N, Gie RP, Zietsman HL, et al. The use of a geographical
     information system (GIS) to evaluate the distribution of tuberculosis
     in a high-incidence community. S Afr Med J 1996;86:40-4.
 17. Bhatt KM, Bhatt SM, Mirza NB. Meningococcal meningitis. East Afr Med J
     1996;73:35-9.
 18. Bifani P, Plikaytis BB, Kapur V, et al. Origin and interstate spread
     of a New York City multidrug-resistant Mycobacterium tuberculosis
     clone family: adverse implications for tuberculosis control in the
     21st century. JAMA 1996;275:452-7.
 19. Birrie H, Balcha F, Bisuneh A, Bero G. Susceptibility of Ethiopian
     Bulinid snails to Schistosoma haematobium from Somalia. East Afr Med J
     1996;73:76-7.
 20. Bloch AB, Simone PM, McCray E, Castro KG. Preventing
     multidrug-resistant tuberculosis. JAMA 1996;275:487-9.
 21. Borus P. Rabies: the emergence of a microbial threat. East Afr Med J
     1996;73:32-4.
 22. Bowden DS, Moaven LD, Locarnini SA. New hepatitis viruses: are there
     enough letters in the alphabet? Med J Aust 1996;164:87-9.
 23. Briem H, Thorsteinsson SB, Gudmundsson S, Erlendsson K, Löve A. The
     epidemiology of AIDS in Iceland. Laeknabladid 1996;82:21-31.
 24. Bronze MS, Dale JB. The reemergence of serious group A streptococcal
     infections and acute rheumatic fever. Am J Med Sci 1996;311:41-54.
 25. Budai J. The present and the future of vaccination in Hungary. LAM
     1996;6:pages not available.
 26. Butler JC, Peters CJ. Lessons learned from the hantavirus and other
     hemorrhagic fever viruses. Am J Med Sci 1996;311:55-9.
 27. Cabreros LJ, Rajendran R, Drimoussis A, Brandstetter RD. Radiographic
     mimics of pneumonia: pulmonary disorders to consider in differential
     diagnosis. Postgrad Med 1996;99:139-42, 145, 146.
 28. Cairney R. Global spread of tuberculosis: worrying trend for Canadian
     physicians. Can Med Assoc J 1996;154:236-8.
 29. Campbell CM, Williams BG. Academic research and HIV/AIDS in South
     Africa. S Afr Med J 1996;86:55-60.
 30. Carballal G. Emerging or reemerging virus. [in Spanish] Medicina
     1996;56:97-101.
 31. Carr A, Boyle MJ. Primary HIV infection. Med J Aust 1996;164:105-6.
 32. Cassiere H, Rodrigues JC, Fein AM. Delayed resolution of pneumonia:
     when is slow healing too slow? Postgrad Med 1996;99:151-4, 157, 158.
 33. Celentano DD, Nelson KE, Suprasert S, et al. Risk factors for HIV-1
     seroconversion infection among young men in northern Thailand. JAMA
     1996;275:122-7.
 34. Chen B, Tao S. Arbovirus survey in China in recent ten years. Chin Med
     J 1996;109:13-5.
 35. Chen D-S. Viral hepatitis in East Asia. J Formos Med Assoc
     1996;95:6-12.
 36. Chopra I, Hodgson J, Metcalf B, Poste G. New approaches for the
     control of infections caused by antibiotic-resistant bacteria: an
     industrial perspective. JAMA 1996;275:401-3.
                                [end of page 366]

 37. Chukwuma C Sr. Microsporidium in AIDS and HIV-infected patients: a
     perspective. East Afr Med J 1996;73:72-5.
 38. Claus JJ, Kuijper EJ, Gans J de. Listeria-meningitis. [Listeria
     meningitis.] Ned Tijdschr Geneeskd 1996;140:113-116.
 39. Clemens J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines
     for developing countries: efficacy or effectiveness? JAMA
     1996;275:390-7.
 40. Clever LH. Infectious diseases—getting out of a deep hole. West J Med
     1996;164:17.
 41. Collignon PJ, Bell JM, and the AGAR. Drug resistant Streptococcus
     pneumoniae: the beginning of the end for many antibiotics? Med J Aust
     1996;164:64-7.
 42. Colquhoun SD. Hepatitis C: a clinical update. Arch of Surg
     1996;130:18-23.
 43. Cunha BA. Community-acquired pneumonia: cost-effective antimicrobial
     therapy. Postgrad Med 1996;99:109, 110, 113, 114, 117-9, 122.
 44. Cunha BA, Ortega AM. Atypical pneumonia: extrapulmonary clues guide
     the way to diagnosis. Postgrad Med 1996;99:123-8, 131, 132.
 45. Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Friedlander AM.
     Pathology of experimental pneumonic plague produced by fraction
     1-positive and fraction 1-negative Yersinia pestis in African Green
     Monkeys (Cercopithecus aethiops). Arch Pathol Lab Med
     1996;120(February):pages not yet available.
 46. Dawson JE, Warner Ck, Standaert S, Olson JG. The interface between
     research and the diagnosis of an emerging tick-borne disease, human
     ehrlichiosis due to Ehrlichia chaffeensis. Arch Intern Med
     1996;156:137-42.
 47. de Quadros CA, Olivé JM, Hersh BS, et al. Measles elimination in the
     Americas: evolving strategies. JAMA 1996;275:224-9.
 48. de Kantor IN, Ritacco V, Barrera L. Is multidrug resistant
     tuberculosis an emerging infection in Buenos Aires? [in Spanish].
     Medicina 1996;56:102-4.
 49. Dhanda V, Das PK, Lal R, Srinivasan R, Ramaiah KD. Spread of lymphatic
     filariasis and reemergence of leishmaniasis in India. Indian J Med Res
     1996;103:46-54.
 50. Doherty RR. HTLV-1 in Australia and Oceania: long term resident or
     recent immigrant? Med J Aust 1996;164:84-6.
 51. Duodenal ulcer: the helicobacterization of a psychosomatic disease?
     Isr J Med Sc 1996;(March):pages not yet available.
 52. Dwyer B. What we should be doing about tuberculosis in Australia. Med
     J Aust 1996;164:62-3.
 53. Eskild A. The AIDS epidemic in Norway - where did it go? Tidsskr Nor
     Laegeforen 1996;116:(January): pages not yet available.
 54. Espersen F. Kampen mod mikroberne - et internationalt anliggende (The
     fight against the microbial threat - an international issue). Ugeskr
     Laeger 1996;158:251-2.
 55. Espinol CH. On the trail of color. JAMA 1996;275:168.
 56. Fadl Alla AI, Fahal AH, Ahmed ME, Hasson MA. Pattern of postoperative
     pyrexia in Khartoum. East Afr Med J 1996;73:78-80.
 57. Fattom AI, Naso R. Staphylococcal vaccines: a realistic dream. Ann Med
     1996;28:43-6.
 58. Feingold DS, Weinberg AN. Group A streptococcal (gas) infections: and
     old adversary reemerging with new tricks. Arch Dermatol
     1996;132:67-70.
 59. Feldman C, Klugman K. Antibiotic-resistant pneumococcal pneumonia. S
     Afr Med J 1996;86:28-30.
 60. File TM, Tan JS, Plouffe JF. Community-acquired pneumonia: what's
     needed for accurate diagnosis. Postgrad Med 1996;99:95-8, 100, 102,
     105-7.
 61. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of
     patients with community-acquired pneumonia: a meta-analysis. JAMA
     1996;275:134-41.
 62. Fodor T. Pataki G. Bacteriology to the diagnosis of tuberculosis. LAM
     1996;6:pages not available.
 63. Fonn S. A blood-result turn-around time survey to improve congenital
     syphilis prevention in a rural area. S Afr Med J 1996;86:67-71.
 64. Frost GW, Johns M. Vaccine-preventable childhood diseases in
     Australia. Med J Aust 1996;164:61.
 65. Fry DE. The reemergence of mycobacterial infections. Arch of Surg
     1996;130:14-7.
 66. Galama JMD. Humane herpesvirussen type 6 en 7, verwekkers van onder
     meer exanthema subitum. [Human herpesviruses type 6 and 7, causative
     agents of e.g. exanthem subitum.] Ned Tijdschr Geneeskd
     1996;140:124-8.
 67. Gaston DA, Zurowski SM. Arcanobacterium haemolyticum pharyngitis and
     exanthem: three case reports and literature review. Arch Dermatol
     1996;132:61-4.
 68. George V, Jesudason MV, John TJ. CAMP test for the identification of
     Vibrio cholerae 0139. Indian J Med Res 1996;103:55-7.
 69. Gilbert GL. Multidrug-resistant tuberculosis: implications for the
     future; lesions from the past. Med J Aust 1996;164:60.
 70. Gilbert GL. Multidrug-resistant tuberculosis: prevention is better
     than cure. Med J Aust 1996;164:120-3.
 71. Githure JI, Ngumbi PM, Anjili CO, et al. Animal reservoirs of
     Leishmaniasis in Marigat, Baringo District, Kenya. East Afr Med J
     1996;73:44-7.
 72. Glanz K, Yang H. Communicating about risk of infectious diseases. JAMA
     1996;275:253-6.
 73. Gold SM, Shott SR, Myer CM III. Membranous laryngotracheobronchitis.
     Arch Pediatr Adolesc Med 1996;150:97-8.
 74. Goldman DA, Weinstein RA, Wenzel RP, et al for the Workshop to Prevent
     and Control the Emergence and Spread of Antimicrobial-Resistant
     Microorganisms in Hospitals. Strategies to prevent and control the
     emergence and spread of antimicrobial-resistant microorganisms in
     hospitals: a challenge to hospital leadership. JAMA 1996;275:234-40.
                                [end of page 367]

 75. Golledge CL, Riley TV. Natural therapy for infectious diseases. Med J
     Aust 1996;164:94-6.
 76. Gool T van, Dankert J. Drie opkomende protozaire infectieziekten in
     Nederland: Cyclospora-, Dientamoeba- en Microspora-infecties. [Three
     emerging protozoal infections in the Netherlands: cyclospora,
     dientamoeba, and microspora infections.] Ned Tijdschr Geneeskd
     1996;140:
 77. Grant CC, Duggan AK, Santosham M, DeAngelis C. Oral prednisone as a
     risk factor for infections in children with asthma. Arch Pediatr
     Adolesc Med 1996;150:58-63.
 78. Gudjónsson Ath, Kristinsson KG, Gudmundsson S. Antibiotic use and
     misuse at the National University Hospital, Iceland. Laeknabladid
     1996;82: 39-45.
 79. Guðmundsdóttir BK, Guðmundsdóttir S, Mangnadóttir B, Helgason S.
     Research in bacterial diseases of salmonid fish. Laeknabladid 1996;82:
     72-7.
 80. Haemophilus influenza infection in Singapore: antimicrobial
     resistance, serotypes and clinical spectrum. Ann Acad Med Singapore
     1996;25(March):pages not yet available.
 81. Hattum J van. Hepatitis C, een ontwakende reus. [Hepatitis C, an
     awakening giant.] Ned Tijdschr Geneeskd 1996;140:119-24.
 82. Haug C. Emerging and reemerging serious infections: doctors around the
     world, unite! Tidsskr Nor Laegeforen 1996;116:(January):pages not yet
     available.
 83. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK.
     Safety and efficacy of the neuroaminidase inhibitor GG167 in
     experimental human influenza. JAMA 1996;275:295-9.
 84. Haynes BF, Putman SB, Winberg JB. Update on the issues of HIV vaccine
     development. Ann Med 1996;28:39-41.
 85. Heath CH, Blackmore TK, Gordon DL. Emerging resistance in Enterococcus
     species. Med J Aust 1996;164:116-9.
 86. Heikkinen T, Ruuskanen O. New prospects in the prevention of otitis
     media. Ann Med 1996;28:23-30.
 87. Herndon RM. Evasion of immulogic defenses and emerging viral threats.
     Arch Neurol 1996;53:23-7.
 88. Hilleman MR. Cooperation between government and industry in combating
     a perceived emerging pandemic through vaccination: the 1976 swine
     influenza example. JAMA 1996;275:241-3.
 89. Hoge CW, Shlim DR, Echeverria P, Rajah R, Herrmann JE, Cross JH.
     Epidemiology of diarrhea among expatriate residents living in a highly
     endemic environment. JAMA 1996;275:533-8.
 90. Hogg GG, Strachan JE, Huayi L, Beaton SA, Robinson PM, Taylor K.
     Non-toxigenic Corynebacterium diphtheriae biovar gravis: evidence for
     an invasive clone in a south-eastern Australian community. Med J Aust
     1996;164:72-5.
 91. Hollister JM, Laing P, Mednick SA. Rhesus incompatibility as a risk
     factor for schizophrenia in male adults. Arch Gen Psychiatry
     1996;53:19-24.
 92. Honan GM, White GW, Eisenberg GM. Spontaneous infectious discitis in
     adults. Am J Med 1996;100:85-9.
 93. Hong T. Human group B rotavirus: adult diarrhea rotavirus. Chin Med J
     1996;109:11-2.
 94. Hoogkamp-Korstanje JAA. Yersiniosis. [Yersiniosis.] Ned Tijdschr
     Geneeskd 1996;140:128-30.
 95. Hopewell PC. Mycobacterium tuberculosisan emerging pathogen? West J
     Med 1996;164:33-5.
 96. Horton R. The infected metropolis. Lancet 1996;347:pages not yet
     available.
 97. Hsueh P-R, Chen H-M, Lu Y-C, Wu J-J. Antimicrobial resistance and
     serotype distribution of Streptococcus pneumoniae strains isolated in
     Southern Taiwan. J Formos Med Assoc 1996;95:29-36.
 98. Hu DJ, Dondero TJ, Rayfield MA, et al. The emerging genetic diversity
     of HIV: the importance of global surveillance for diagnostics,
     research, and prevention. JAMA 1996;275:210-6.
 99. Huang G, Lin T. Bacterial L-forms research in China. Chin Med J
     1996;109:18-20.
100. Hughes JM. Emerging pathogens—an epidemiologist's perspective on the
     problem and priorities for the future. West J Med 1996;164:21-2.
101. Hung C-C, Chen Y-C, Chang S-C, Luh KT, Hsieh W-C. Clinical study of
     nosocomial candidemia in a university hospital in Taiwan. J Formos Med
     Assoc 1996;95:19-28.
102. Indriðason ÓS, Kristinsson KG, Ásmundsson P, Böðvarsson M. The
     incidence of infection associated with peritoneal dialysis.
     Laeknabladid 1996;82:53-9.
103. Infectious diseases - the old and the new. Ann Acad Med Singapore
     1996;25(March):pages not yet available.
104. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infections
     of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and
     conjunctival route of exposure. Arch Pathol Lab Med 1996;120:140-55.
105. Jacob John T. Emerging and reemerging global microbial threats. Natl
     Med J India 1996;9:1-2.
106. Jankovics I. The influenza viruses: past, present and future. LAM
     1996;6:pages not available.
107. Jernigan DB, Cetron MS, Breiman RF. minimizing the impact of
     drug-resistant Streptococcus pneumoniae (DRSP): a strategy from the
     DRSP Working Group. JAMA 1996;275:206-9.
108. John TJ. Emerging and reemerging bacterial pathogens in India. Indian
     J Med Res 1996;103:4-18.
109. John TJ, Jesudason MV, Lalitha MK, et al. Melioidosis in India: tip of
     the iceberg. Indian J Med Res 1996;103:64-5.
110. Johnson RT. Emerging viral infections. Arch Neurol 1996;53:18-22.
111. Johnson PDR, Veitch MGK, Leslie DE, Flood PE, Hayman JA. The emergence
     of Mycobacterium ulcerans infection near Melbourne. Med J Aust
     1996;164:76-8.
112. Jones D. Emergence of antibiotic resistance: role of ophthalmology.
     Arch Ophthalmol 1996;114:91-2.
                                [end of page 368]

113. Jónsdóttir KE, Hansen H, Arnórsson VH, Laxdal Th, Stefánsson M.
     Immunization against Haemophilus influenzae type b in Iceland: results
     after six years use of PRP-D (ProHIBiT®). Laeknabladid 1996;82:32-8.
114. Joyce T, McGuigan KG, Elmore-Meegan M, Conroy RM. Prevalence of
     entropathogens in stools of rural Maasai children under five years of
     age in the Maasailand region of the Kenyan Rift Valley. East Afr Med J
     1996;73:59-62.
115. Joynt RT. Microbial threats. Arch Neurol 1996;53:17.
116. Jupp PG, A Kemp. What is the potential for future outbreaks of
     chikungunya, dengue and yellow fever in southern Africa. S Afr Med J
     1996;86:35-7.
117. Kager PA, Wetsteyn JCFM. Malaria en geneesmiddelenresistentie.
     [Malaria and drug resistance.]. Ned Tijdschr Geneeskd 1996;140:151-5.
118. Kar NCAJ van de, Heuvelink AE, Boer E de, Monnens LAH. Infecties met
     verocytotoxine-producerende Escherichia coli en het
     hemolytisch-uremisch syndroom. [Infections with
     verotoxinogeneic-producing Escherichia coli and the hemolytic-uremic
     syndrome.] Ned Tijdschr Geneeskd 1996;140:134-7.
119. Kelleher AD, Orth D. Early HIV-induced immune deficiency. Med J Aust
     1996;164:107-8.
120. Kent C. Microbial menaces: long neglected system strains to respond to
     a rising threat. AMNews 1996;39:9-12.
121. Kent C. Microbial menaces: new era feared, when common bacteria will
     kill again. AMNews 1996;39:9-12.
122. Khan AS. Hantavirus pulmonary syndrome in Florida: association with
     the newly identified Black Creek Canal Virus. Am J Med 1996;100:46-8.
123. Kilstein J, Sala R, Greca A, Battagliotti C. Oxygen radicals and HIV
     infection: can antioxidants be of any use? [in Spanish]. Medicina
     1996;56:105-7.
124. King DE. Bronchodilators and antibiotics in the treatment of acute
     bronchitis. Arch Fam Med 1996;5
125. Kolmos HJ. Antibiotika i almen praksis (Antibiotics in general
     practice). Ugeskr Laeger 1996;158:258-60.
126. Kolmos HJ. Rationel anvendelse af antibiotika på hospital (The
     rationale for the use of antibiotics in hospitals). Ugeskr Laeger
     1996;158:255-7.
127. Koo D, Maloney K, Tauxe R. Epidemiology of diarrheal disease outbreaks
     on cruise ships: 1989 - 1993. JAMA 1996;275:545-7.
128. Koziel MJ. Immunology of viral hepatitis. Am J Med 1996;100:98-109.
129. Kristinsson KG. Epidemiology of penicillin resistant pneumococci.
     Laeknabladid 1996;82:9-19.
130. Kullberg BJ, Voss A. Het veranderend patroon van Candida-infecties:
     andere soorten en meer resistentie. [The changing pattern of Candida
     infections.] Ned Tijdschr Geneeskd 1996;140:148-151.
131. Lawson KA. Australian contributions to the study of infectious
     disease. Med J Aust 1996;164:113-5.
132. Lederberg J. Infection emergent. JAMA 1996;275:243-5.
133. LeDuc JW. World Health Organization: strategy for emerging infectious
     diseases. JAMA 1996;275:318-20.
134. Lee C-M, NG S-H, Wan Y-L, Tsai C-H. Gastric actinomycosis. J Formos
     Med Assoc 1996;95:66-8.
135. Lee T, Esterhuyse T, Steinberg M, Schneider H. Demographic modelling
     of the HIV/AIDS epidemic on the Soweto population- results and health
     policy implications. S Afr Med J 1996;86:60-3.
136. Lore W. Emerging and reemerging global microbial threats. East Afr Med
     J 1996;73:1-2.
137. Ludwig E. Changes in antibiotic usage. LAM 1996;6:pages not available.
138. Mackenzie JS, Smith DW. Mosquito-borne viruses and epidemic
     polyarthritis. Med J Aust 1996;164:90-3.
139. MacLean JD, Arthur JR, Ward BJ, Gyorkos TW, Curtis MA, Kokaskin E. The
     North American liver fluke: Metorchis conjunctus. Lancet
     1996;347:154-8.
140. Magnason S, Gudmundsson S, Stefánsson TSv, Erlendsdóttir H,
     Baldursdóttir L, Kristinsson KG. Nosocomial infections in the ICU at
     Landspitalinn: an interim report. Laeknabladid 1996;82:60-5.
141. Mainous AG III, Zoorob RJ, Hueston WJ. Current management of acute
     bronchitis in ambulatory care: the use of antibiotics and
     bronchodilators. Arch Fam Med 1996;5
142. Manders SM, Heymann WR, Atillasoy E, Kleeman J, Schlievert PM.
     Recurrent toxin-mediated perineal eyrhtema. Arch Dermatol
     1996;132:57-60.
143. Marriott D, McMurchie M. HIV and advanced immune deficiency. Med J
     Aust 1996;164:111-2.
144. Martínez-Vázquez JM, Cabarcos A. Present and future of the retroviral
     therapy. An Med Intern 1995;13:1-3.
145. McClure HM, Novembre FJ. Simian immunodeficiency virus variants:
     threat of new retroviruses. Am J Med Sci 1996;311:30-3.
146. McIntyre J. HIV/AIDS in South Africa - a relentless progression? S Afr
     Med J 1996;86:27-8.
147. Meer JWM van der, Hoogkamp-Korstanje JAA, Kager PA, Overbeke AJPM.
     Opdujkende pathogenen. [Emerging pathogens.] Ned Tijdschr Geneeskd
     1996;140:116-8.
148. Meis JFGM, Neeleman C. Resistentieproblemen bij Streptococcus
     pneumoniae. [Resistance problems with Streptococcus pneumoniae.] Ned
     Tijdschr Geneeskd 1996;140:141-4.
149. Mekasha A, Meharie S. Outbreak of louse-borne relapsing fever in
     Jimma, south western Ethiopia. East Afr Med J 1996;73:54-8.
150. Mhalu FS, Lyamuya E. Human immunodeficiency virus infection and AIDS
     in East Africa: challenges and possibilities for prevention and
     control. East Afr Med J 1996;73:13-9.
151. Möller AD, Guðmundsson S, Gunnarsdóttir K, Jónsson ÓTh. Infections in
     the intensive care unit in Reykjavik City Hospital. Laeknabladid
     1996;82:46-52.
                                [end of page 369]

152. Morcillo N, Alito A, Romano MI, et al. A multidrug resistant
     tuberculosis outbreak in Buenos Aires: DNA fingerprinting analysis.
     Medicina 1996;56:45-7.
153. Mqoqi NP, Appleton CC, Dye AH. Prevalence and intensity of Schistosoma
     haematobium urinary schistosomiasis in the Port St Johns district. S
     Afr Med J 1996;86:76-80.
154. Mugerwa RD, Marum LH, Serwadda D. Human immunodeficiency virus/AIDS in
     Uganda. East Afr Med J 1996;73:20-26.
155. Mulhausen PL, Harrel LJ, Weinberger M, et al. Contrasting
     methicillin-resistant Staphylococcus aureus colonization in Veterans
     Administration and community nursing homes. Am J Med 1996;100:24-31.
156. Mutinga MJ. Phlebotomine sandflies (Diptera Psychodidae) their
     importance and some aspects of control. East Afr Med J 1996;73:48-9.
157. Nelson AM, Sledzik PS, Mullick FG. The Army Medical Museum/Armed
     Forces Institute of Pathology and emerging infections: from camp
     fevers and diarrhea during the American Civil War in the 1860s to
     global molecular epidemiology and pathology in the 1990s. Arch Pathol
     Lab Med 1996;120:129-33.
158. Nelson RP, Price LJ, Halsey AB, et al. Diagnosis of pediatric human
     immunodeficiency virus infection by means of a commercially available
     polymerase chain reaction gene amplification. Arch Pediatr Adolesc Med
     1996;150:40-5.
159. Nolte KB, Simpson GL, Parrish RG. Emerging infectious agents and the
     forensic pathologist: the New Mexico model. Arch Pathol Lab Med
     1996;120:125-8.
160. Olafsson M, Sigurdsson JA. Increased antimicrobial resistance in
     urinary tract infections. Laeknabladid 1996;82:66-70.
161. Olliaro P, Cattani J, Wirth D. Malaria: the submerged disease. JAMA
     1996;275:230-3.
162. Oloo AJ, Vulule JM, Koech DK. Some emerging issues on the malaria
     problem in Kenya. East Afr Med J 1996;73:50-3.
163. Osborn JE. Reemerging pathogens. West J Med 1996;164:23-4.
164. Parisi MN, Enría D, Pini N, Sabattini M. Retrospective detection of
     clinical infection caused by hantavirus. Medicina 1996;56:1-13.
165. Patz JA, Epstein PR, Burke TA, Balbus JM. Global climate change and
     emerging infectious diseases. JAMA 1996;275:217-23.
166. Peters CJ. Emerging infections—ebola and other filoviruses. West J Med
     1996;164:36-8.
167. Petersen EA. Emerging infectious diseases. Arch Intern Med
     1996;156:124.
168. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR.
     Tuberculosis prophylaxis in the homeless: a trial to improve adherence
     to referral. Arch Intern Med 1996;156:161-5.
169. Pinner RW. Addressing the challenges of emerging infectious diseases.
     Am J Med Sci 1996;311:3-8.
170. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious
     diseases mortality in the United States. JAMA 1996;275:189-93.
171. Plouffe JF, Breiman RF, Facklam RR, for Franklin County Pneumonia
     Study Group. Bacteremia with Streptococcus pneumoniae: implications
     for therapy and prevention. JAMA 1996;275:194-8.
172. Povinelli M, Remafedi G, Tao G. Trends and predictors of human
     immunodeficiency virus antibody testing by homosexual and bisexual
     adolescent males, 1980-1994. Arch Pediatr Adolesc Med 1996;150:33-8.
173. Prabhakar R. Tuberculosis--the continuing scourge of India. Indian J
     Med Res 1996;103:19-25.
174. Prado V. Emerging infections: a new problem? Rev Med Chil
     1996;124:1-4.
175. Pretorius GS, Sirgel FA, Schaaf HS, van Helden PD, Victor TC.
     Rifampicin resistance in Mycobacterium tuberculosis - rapid detection
     and implications in chemotherapy. S Afr Med J 1996;86:50-5.
176. Quinlan KP, Hayani KC. Vitamin A and respiratory syncytial virus
     infection: serum levels and supplementation trial. Arch Pediatr
     Adolesc Med 1996;150:25-30.
177. Rathinamisivakumar, Ratnam S, Sureshbabu L, Natarajaseenivasan K.
     Leptospiral antibodies in patients with recurrent ophthalmic
     involvement. Indian J Med Res 1996;103:66-8.
178. Reichman L. How to ensure the continual resurgence of tuberculosis.
     Lancet 1996;347:pages not yet available.
179. Samore MH, Venkatarami L, DeGirol PC, et al. Clinical and molecular
     epidemiology of sporadic and clustered cases of nosocomial Clostridium
     difficile diarrhea. Am J Med 1996;100:32-40.
180. Sande M. The public health risk of emerging and reemerging infections.
     West J Med 1996;164:18-20.
181. Sanders EJ, Tukei PM. Yellow fever an emerging threat for Kenya and
     other East African countries. East Afr Med J.1996;73:10-2.
182. Satyanarayana K, Medappa N. Emerging and reemerging infections. Indian
     J Med Res 1996;103:1-3.
183. Schellekens JFP. Kattekrabziekte en andere infecties met
     Bartonella-species. [Cat-scratch disease and other infections of the
     Bartonella species.] Ned Tijdschr Geneeskd 1996;140:144-7.
184. Schmitt ED, Camozzi S, Vigo G, Tadini G. Tinea corporis in an HIV-1
     infected patient resembled dermatophyte colonies on Sabouraud's agar.
     Arch Dermatol 1996;132:233-4.
185. Schmitt H-J, von König CHW, Neiss A, et al. Efficacy of an acellular
     pertussis vaccine in infants after household exposure to pertussis.
     JAMA 1996;275:37-41.
186. Schwartz DA, Bryan RT. Infectious disease pathology and emerging
     infections: are we prepared? Arch Pathol Lab Med 1996;120:117-24.
                                [end of page 370]

187. Schwartz DA, Sobottka I, Leitch GJ, Cali A, Visvesvara GS. Pathology
     of microsporidiosis: emerging parasitic infections in patients with
     AIDS. Arch Pathol Lab Med 1996;120:173-88.
188. Shah K, Davis C, Wilson J, Parekh B. Chimeric synthetic peptides as
     antigens for detection of the antibodies to HIV-1 and HIV-2. East Afr
     Med J 1996;73:63-6.
189. Sharma VP. Reemergence of malaria in India. Indian J Med Res
     1996;103:26-45.
190. Sharp B, le Sueur D. Malaria control in South Africa - the past, the
     present and selected implications for the future. S Afr Med J
     1996;86:83-9.
191. Somekh E, Abishai V, Hanani M, Gutman R, Mintz M. The clinical
     significance of Pseudomonas aeruginosa isolation from stool of
     neonates. Arch Pediatr Adolesc Med 1996;150:108-9.
192. Soni PN, Tait DR, Gopaul W, Sathar MA, Simjee AE. Hepatitis C virus
     infection in chronic liver disease in Natal. S Afr Med J 1996;86:80-3.
193. Speed BR, Gerrard MP, Kennett ML, Carron MG, Harvey BM. Viral
     haemorrhagic fevers - current status, future threats. Med J Aust
     1996;164:79-83.
194. St. Geme JW III. Progress towards a vaccine for nontypable Haemophilus
     influenzae. Ann Med 1996;28:31-7.
195. Stanton BF, Li X, Galbraith J, Feigelman S, Kaljee L. Sexually
     transmitted diseases, human immunodeficiency virus, and pregnancy
     prevention: combined contraceptive practices among urban
     African-American early adolescents. Arch Pediatr Adolesc Med
     1996;150:17-24.
196. SAtephens DS, Farley MM. Emerging and reemerging microbial threats. Am
     J Med Sci 1996;311:1-2.
197. Stevens DL. Group A streptococcus—from basic science to clinical
     disease. West J Med 1996;164:25-7.
198. Stewart GJ. HIV medicine in the mainstream. Med J Aust 1996;164:97-8.
199. Stewart GJ, Irvine SS, Scott M, et al. Strategies of care in managing
     HIV. Med J Aust 1996;164:99-104.
200. Strange P, Skov L, Lisby S, Lovgreen P. Stahpyloccocal enterotoxin B
     applied on intact normal and intact atopic skin induces dermatitis.
     Arch Dermatol 1996;132:27-33.
201. Straub I. Epidemiological situation in Hungary: past, present and
     future. LAM 1996;6:pages not available.
202. Su I-J, Huang L-M, Wu S-J, et al. Detection and sequence analysis of a
     new herpesvirus-like agent (KSHV) in AIDS and non-AIDS Kaposi's
     sarcoma in Taiwan: a comparison with related herpesviruses. J Formos
     Med Assoc 1996;95:13-8.
203. Subtype B isolates of the human immunodeficiency virus type 1 detected
     in Australia. Ann Acad Med Singapore 1996;25(March):pages not yet
     available.
204. Susser E, Neugebauer R, Hoek HW, et al. Schizophrenia after prenatal
     famine: further evidence. Arch Gen Psychiatry 1996;53:25-31.
205. Szalka A, Printz G. Hanta viruses and the pulmonal syndrome caused by
     hanta virus. LAM 1996;6:pages not available.
206. Taller AM, Asher DM, Pomeroy KL, et al. Search for viral nucleic acid
     sequences in brain tissues of patients with schizophrenia using nested
     polymerase chain reaction. Arch Gen Psychiatry 1996;53:32-40.
207. Tamássy K, Microbiological diagnosis and complex treatment of
     gastrobulbar alterations: the role of Helicobacter pylori. LAM
     1996;6:pages not available.
208. Tambi A, Tambi T, KuiÓec-TepeÓ N. Prevalence and antibiotic
     sensitivity pattern variations of bacterial isolates in different
     settings and different periods of time. Acta Med Croatica 1996;pages
     not available.
209. Tappero JW, Khan AS, Pinner RW, et al. Hantavirus pulmonary syndrome
     1993: utility of an emergency, telephone-based national surveillance
     system. JAMA 1996;275:398-400.
210. Tenover FC, McGowan JE. Reasons for the emergence of antibiotic
     resistance. Am J Med Sci 1996;311:9-16.
211. Tenover FC, Hughes JM. The challenges of emerging infectious diseases:
     development and spread of multiply resistant bacterial pathogens. JAMA
     1996;275:300-4.
212. Thomas DL, Gruninger SE, Siew C, et al. Occupational risk of hepatitis
     C infections among general dentists and oral surgeons in North
     America. Am J Med 1996;100:41-5.
213. Thompson J. Enterokokken: toename van het aantal infecties en van
     antibioticumresistentie. [Enterococci: increase of the number of
     infections and of antimicrobial resistance.] Ned Tijdschr Geneeskd
     1996;140:130-3.
214. Thornsberry C. Emerging resistance in clinically important gram
     positive cocci. West J Med 1996;164:28-32.
215. Thorsteinsson SB. Infectious diseases in Iceland: current issues and
     future challenges. Laeknabladid 1996;82:6-7.
216. Tompkins LS. Bartonella species infections, including cat-scratch
     disease, trench fever, and bacillary angiomatosis—what molecular
     techniques have revealed. West J Med 1996;164:39-41.
217. Tswana S, Chetsanga C, Nyström L, Moyo S, Nzara M, Chieza L. A
     sero-epidemiological cross-sectional study of hepatitis B virus in
     Zimbabwe. S Afr Med J 1996;86:72-5.
218. Tukei PM. The threat of Marburg and Ebola viral haemorrhagic fever in
     Africa. East Afr Med J 1996;73:27-31.
219. Turnidge JD, Nimmo GR, Francis G, and the AGAR. Evolution of
     resistance in Staphylococcus areus in Australian teaching hospitals.
     Med J Aust 1996;164:68-71.
220. Ujhelyi E. The update of the croup-syndrome. LAM 1996;6:pages not
     available.
221. Vandenbroucke-Grauls CMJE. Meticilline-resistente Staphylococcus
     epidermidis. [Meticillin-resistant Staphylococcus epidermidis.] Ned
     Tijdschr Geneeskd 1996;140:138-41.
                                [end of page 371]

222. Vogel P, Abplanalp D, Kell W, et al. Venezuelan equine encephalitis in
     BALB/c mice: kinetic analysis of central nervous system infection
     following aerosol or subcutaneous inoculation. Arch Pathol Lab Med
     1996;120:164-72.
223. Waiyaki PG. Cholera: its story in Africa with special reference to
     Kenya and other east African countries. East Afr Med J 1996;73:40-3.
224. Walker DH, Barbour AG, Oliver JH, et al. Emerging bacterial zoonotic
     and vector-borne diseases: ecologic and epidemiologic factors. JAMA
     1996;275:463-9.
225. Wallace MR, Sharp TW, Smoak B, et al. Malaria among US troops in
     Somalia. Am J Med 1996;100:49-55.
226. Wann S-R, Liu Y-C, Yen M-Y, Wang J-S, Chen Y-S, Wang J-H, Cheng D-L.
     Endogenous Escherichia coli endophthalmitis. J Formos Med Assoc
     1996;95:56-60.
227. Warren R, Hauman J, Beyers N, et al. Unexpectedly high strain
     diversity of M tuberculosis in a high incidence community. S Afr Med J
     1996;86:45-9.
228. Weissenbacher M, Cura E, Segura E, et al. Serological evidence of
     human hantavirus infection in Argentina, Bolivia and Uruguay. Medicina
     1996;56:17-22.
229. Whitcup SM. Ocular manifestations of AIDS. JAMA 1996;275:142-4.
230. Wilkinson D, de Cock KM. Tuberculosis control in South Africa - time
     for a new paradigm? S Afr Med J 1996;86:33-5.
231. Wilkinson D, Moore DAJ. HIV-related tuberculosis in South Africa -
     clinical features and outcome. S Afr Med J. 1996;86:64-7.
232. Williamson H. Treatment of acute bronchitis: there's much work to be
     done. Arch Fam Med 1996;5
233. Winker MA, Flanagin A. Infectious diseases: a global approach to a
     global problem. JAMA 1996;275:245-6.
234. Woelffer GB, Bradford WZ, Paz A, Small PM. A computer assisted
     molecular epidemiologic approach for confronting the reemergences of
     tuberculosis. Am J Med Sci 1996;311:17-22.
235. Xu J, Cheng B, Wu Y, et al. A new diarrhea pathogen:
     entero-adherent-invasive-toxigenic Escherichia coli. Chin Med J
     1996;109:16-7.
236. Yahav J, Oderda G, Diver-Haber A, et al. Serum pepsinogen I in
     childhood Helicobacter pylori gastritis: its relation to mucosal
     peptic activity. Isr J Med Sc 1996;32:56-9.
237. Yao C, Wang W-W, Chung Y-M, Su Y-L, Liu C-Y, Chen Y-M A.
     Transfusion-transmitted AIDS: report of the first case in Taiwan. J
     Formos Med Assoc 1996;95:51-5.
238. Young LHY. Therapy for cytomegalovirus retinitis: still no silver
     lining. JAMA 1996;275:149-50.
239. Ytterdahl T. Tropical diseases: an interview with David Stevenson, MD.
     Tidsskr Nor Laegeforen 1996;116:(January):pages not yet available.
240. Zaki SR, Khan AS, Goodman, et al. Retrospective diagnosis of
     hantavirus pulmonary syndrome, 1978-1993: implications for emerging
     infectious diseases. Arch Pathol Lab Med 1996;120:134-9.
241. Zhu CM. Comments on some new viruses associated with old diseases in
     China. Chin Med J 1996;109:5-10.

---------------------------------------------------------------------------